Clinical Trial Update: BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on combining BTLA inhibitor JS004 with toripalimab and chemotherapy as perioperative treatment for resectable locally advanced thoracic eso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• JS004 (JS004)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Henan Provincial People's Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING